The company AsurBrok and the Biomedical Research Institute of Lleida (IRBLleida) sign a new collaboration agreement to promote research in Lleida.
AsurBrok is an insurance broker with more than 31 years of history and who works every day to give the best of themselves and get their customers to renew their confidence year after year.
The company signs this collaboration agreement for the fourth consecutive year. These collaborations allow research on very relevant diseases such as cancer, stroke, multiple sclerosis, diabetes, the nervous system, the cardiovascular system, among others, and help provide better services to the population.
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The results show that adenocarcinoma exhibits much more active and fun...
